header
Local cover image
Local cover image
Image from OpenLibrary

Metformin as An ADD on therapy in the treatment of hepatitis C virus Egyptian patients / Hossam Eldin Shaaban ; Supervised Taher Elzanaty , Ayman Foda , Sameh Seif Eldin

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Hossam Eldin Shaaban , 2013Description: 98 P. : facsimiles ; 25cmOther title:
  • استخدام عقار الميتفورمين كعلاج إضافي لمرضى الالتهاب الكبدي الفيروسي سي المصريين [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Internal Medicine Summary: HCV is a major health problem in Egypt. Combined therapy with pegylated interferon and ribavirin is the only evidence based treatment to HCV genotype 4. Insulin resistance is linked to non response to combined therapy. The study was carried out to study the effect of adding metfurmin to the combined therapy in patients with insulin resistance. Statistical studies were carried out on two groups. One group took triple therapy with pegylated interferon, ribavirin, and metfurmin. The second group took combined therapy. Statistical analysis revealed no significant dffirence between the two groups at week 72 (SVR)
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.Ph.D.2013.Ho.S (Browse shelf(Opens below)) Not for loan 01010110063554000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.Ph.D.2013.Ho.S (Browse shelf(Opens below)) 63554.CD Not for loan 01020110063554000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Internal Medicine

HCV is a major health problem in Egypt. Combined therapy with pegylated interferon and ribavirin is the only evidence based treatment to HCV genotype 4. Insulin resistance is linked to non response to combined therapy. The study was carried out to study the effect of adding metfurmin to the combined therapy in patients with insulin resistance. Statistical studies were carried out on two groups. One group took triple therapy with pegylated interferon, ribavirin, and metfurmin. The second group took combined therapy. Statistical analysis revealed no significant dffirence between the two groups at week 72 (SVR)

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image